LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | MK2206 | 0.5779 |
| MCF 10A | OSI-027 | 0.5769 |
| MCF7 | Crizotinib | 0.5747 |
| BT-20 | Dovitinib | 0.5738 |
| MDA-MB-231 | Celastrol | 0.5688 |
| Hs 578T | Withaferin A | 0.5674 |
| MDA-MB-231 | PI103 | 0.5673 |
| MCF7 | Saracatinib | 0.5672 |
| SK-BR-3 | PF562271 | 0.5617 |
| SK-BR-3 | JW-7-24-1 | 0.5594 |
| MCF7 | GSK 690693 | 0.5584 |
| BT-20 | ZSTK474 | 0.5547 |
| MDA-MB-231 | HG-6-64-01 | 0.5492 |
| MCF7 | Palbociclib | 0.5482 |
| MCF7 | Alpelisib | 0.5462 |
| Hs 578T | Selumetinib | 0.5457 |
| MCF 10A | PF562271 | 0.5425 |
| MDA-MB-231 | Palbociclib | 0.5401 |
| MDA-MB-231 | NVP-TAE684 | 0.5395 |
| SK-BR-3 | Dovitinib | 0.5306 |
| Hs 578T | Palbociclib | 0.5293 |
| MCF 10A | AZD7762 | 0.5280 |
| BT-20 | Celastrol | 0.5273 |
| Hs 578T | GSK1059615 | 0.5241 |
| Hs 578T | ZSTK474 | 0.5235 |